Mutations

South Africa suspends AstraZeneca vaccine drive following small clinical trial

Mon, 2021-02-08 02:56 — mike kraft

South Africa suspends AstraZeneca vaccine drive JOHANNESBURG (AP) — South Africa has suspended plans to inoculate its front-line health care workers with the Oxford-AstraZeneca vaccine after a small clinical trial suggested that it isn't... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about South Africa suspends AstraZeneca vaccine drive following small clinical trial
1 comment
Log in or register to post comments

Overview of What scientists know about variants and Covid-19 vaccines

Sun, 2021-02-07 17:42 — mike kraft

What scientists know about the new variants and the Covid-19 vaccines When it comes to the new variants and the Covid-19 vaccines, some of the news is very good. But some is potentially very bad indeed. Andrew Joseph STAT

here is now real evidence that at least one coronavirus variant seems to elude some of the power of Covid-19 vaccines. What, exactly, that means for the pandemic is still being sussed out.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Overview of What scientists know about variants and Covid-19 vaccines
Log in or register to post comments

TheHill.com AstraZeneca vaccine works against UK coronavirus variant: study

Fri, 2021-02-05 16:36 — mike kraft

AstraZeneca vaccine works against UK coronavirus variant: study The AstraZeneca-Oxford COVID-19 vaccine protects against a more transmissible variant of the virus first identified in the United Kingdom, according to research published Friday. Peter Sullivan TheHill

The AstraZeneca-Oxford COVID-19 vaccine protects against a more transmissible variant of the virus first identified in the United Kingdom, according to research published Friday.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about TheHill.com AstraZeneca vaccine works against UK coronavirus variant: study
Log in or register to post comments

UK backs CureVac effort to make vaccine for COVID variants U.S. rushes to catch up

Fri, 2021-02-05 15:15 — mike kraft

UK backs CureVac effort to make vaccine for COVID variants LONDON (AP) — The U.K. government announced Friday that it plans to work with a German biopharmaceutical company to develop vaccines targeting emerging variants of COVID-19 as public health... AP NEWS

LONDON (AP) — The U.K. government announced Friday that it plans to work with a German biopharmaceutical company to develop vaccines targeting emerging variants of COVID-19 as public health officials call for new tools to keep the virus in check as it mutates.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about UK backs CureVac effort to make vaccine for COVID variants U.S. rushes to catch up
Log in or register to post comments

Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples

Wed, 2021-02-03 15:26 — mike kraft

Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples In experiments and clinical trials, mutation appears to limit the effectiveness of vaccines. Joel Achenbach, William Booth Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples
Log in or register to post comments

Oxford finds COVID-19 shot 76% effective for 3 months after single dose

Tue, 2021-02-02 19:18 — mike kraft

Oxford finds COVID-19 shot 76% effective for 3 months after single dose Oxford University and AstraZeneca's COVID-19 vaccine showed in a study it had 76% efficacy against symptomatic infection for three months after a single dose, which increased if the second shot is delayed, backing Britain's vaccine rollout policy. Alistair Smout U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Oxford finds COVID-19 shot 76% effective for 3 months after single dose
Log in or register to post comments

Small study suggests Pfizer's COVID-19 vaccine less effective against South African variant

Tue, 2021-02-02 19:07 — mike kraft

Study suggests Pfizer's COVID-19 vaccine less effective against South African variant The Pfizer-BioNTech COVID-19 vaccine may be less able to protect against infection with a South African variant of the virus that has a worrying mutation, according to results of a British study released on Tuesday. Kate Kelland U.S.

LONDON (Reuters) - The Pfizer-BioNTech COVID-19 vaccine may be less able to protect against infection with a South African variant of the virus that has a worrying mutation, according to results of a British study released on Tuesday.

Country / Region Tags:

General Topic Tags: